mannitol has been researched along with acyclovir in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 10 (58.82) | 29.6817 |
| 2010's | 6 (35.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Chatterjee, J; Gilon, C; Hoffman, A; Kessler, H; Marinelli, L; Ovadia, O; Zahn, G | 1 |
| Gilon, C; Hess, S; Hoffman, A; Jelinek, R; Ovadia, O; Qadri, B; Salitra, Y; Senderovich, H; Shalev, DE; Sheynis, T; Yehezkel, T | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bando, H; Hashida, M; Kitagawa, S; Koyama, Y; Takakura, Y; Yamashita, F | 1 |
| Katragadda, S; Mitra, AK; Talluri, RS | 1 |
| Keilson, G; Lu, RP | 1 |
| Bagchi, T; Jogani, V; Mishra, AK; Mishra, P; Misra, A; Shah, P | 1 |
| Higuchi, WI; Ibrahim, SA; Li, SK; Xu, Q | 1 |
| Nandhagopal, R | 1 |
1 review(s) available for mannitol and acyclovir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
16 other study(ies) available for mannitol and acyclovir
| Article | Year |
|---|---|
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Multiple N-methylation by a designed approach enhances receptor selectivity.
Topics: Binding Sites; Drug Design; Integrin alpha5beta1; Integrin alphaVbeta3; Ligands; Methylation; Models, Molecular; Molecular Conformation; Oligopeptides; Peptides, Cyclic; Platelet Glycoprotein GPIIb-IIIa Complex; Structure-Activity Relationship | 2007 |
Effect of structural and conformation modifications, including backbone cyclization, of hydrophilic hexapeptides on their intestinal permeability and enzymatic stability.
Topics: Animals; Biological Transport; Caco-2 Cells; Cell Membrane Permeability; Cyclization; Humans; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Liposomes; Magnetic Resonance Spectroscopy; Mannitol; Methylation; Microvilli; Oligopeptides; Peptides, Cyclic; Protein Conformation; Rats; Structure-Activity Relationship | 2007 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vivo and in vitro analysis of skin penetration enhancement based on a two-layer diffusion model with polar and nonpolar routes in the stratum corneum.
Topics: Acyclovir; Animals; Azepines; Diffusion; Epidermis; In Vitro Techniques; Mannitol; Mathematics; Parabens; Rats; Rats, Wistar; Skin Absorption; Tissue Distribution | 1994 |
Simultaneous modulation of transport and metabolism of acyclovir prodrugs across rabbit cornea: An approach involving enzyme inhibitors.
Topics: Acyclovir; Aminopeptidases; Animals; Antiviral Agents; Biological Transport; Carboxylic Ester Hydrolases; Cell Membrane Permeability; Cells, Cultured; Cornea; Diazepam; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hydrolysis; Kinetics; Leucine; Male; Mannitol; p-Chloromercuribenzoic Acid; Peptides; Prodrugs; Rabbits; Valacyclovir; Valine | 2006 |
Combination regimen of methylprednisolone, IV immunoglobulin, and plasmapheresis early in the treatment of acute disseminated encephalomyelitis.
Topics: Acyclovir; Adult; Anti-Inflammatory Agents; Antiviral Agents; Ceftriaxone; Combined Modality Therapy; Encephalomyelitis, Acute Disseminated; Humans; Immunoglobulins, Intravenous; Magnetic Resonance Imaging; Male; Mannitol; Methylprednisolone; Plasma Exchange; Plasmapheresis; Respiratory Tract Infections; Time Factors; Vancomycin | 2006 |
In vitro assessment of acyclovir permeation across cell monolayers in the presence of absorption enhancers.
Topics: Acyclovir; Animals; Antiviral Agents; beta-Cyclodextrins; Biological Transport; Caco-2 Cells; Cell Line; Cell Survival; Chitosan; Dogs; Drug Synergism; Electric Impedance; Excipients; Humans; Kidney; Mannitol; Permeability; Sodium Dodecyl Sulfate | 2008 |
Ion-exchange membrane assisted transdermal iontophoretic delivery of salicylate and acyclovir.
Topics: Acyclovir; Administration, Cutaneous; Antiviral Agents; Biological Transport; Electric Impedance; Electroosmosis; Epidermis; Humans; Ion Exchange; Iontophoresis; Mannitol; Skin Absorption; Sodium Salicylate; Solubility | 2009 |
Fever with seizure and confusion.
Topics: Acyclovir; Adult; Anticonvulsants; Antiviral Agents; Brain; Brain Edema; Confusion; Diuretics, Osmotic; DNA, Viral; Encephalitis, Herpes Simplex; Fever; Herpesvirus 1, Human; Humans; Male; Mannitol; Polymerase Chain Reaction; Seizures; Temporal Lobe; Tomography, X-Ray Computed | 2016 |